Molecular Analysis and Informatics
Proc. SPIE 4623, Functional Monitoring and Drug-Tissue Interaction, pg 1 (5 June 2002); doi: 10.1117/12.469436
Proc. SPIE 4623, Functional Monitoring and Drug-Tissue Interaction, pg 13 (5 June 2002); doi: 10.1117/12.469444
Proc. SPIE 4623, Functional Monitoring and Drug-Tissue Interaction, pg 27 (5 June 2002); doi: 10.1117/12.469450
Proc. SPIE 4623, Functional Monitoring and Drug-Tissue Interaction, pg 38 (5 June 2002); doi: 10.1117/12.469458
Proc. SPIE 4623, Functional Monitoring and Drug-Tissue Interaction, pg 47 (5 June 2002); doi: 10.1117/12.469464
Proc. SPIE 4623, Functional Monitoring and Drug-Tissue Interaction, pg 85 (5 June 2002); doi: 10.1117/12.469471
Proc. SPIE 4623, Functional Monitoring and Drug-Tissue Interaction, pg 59 (5 June 2002); doi: 10.1117/12.491254
Proc. SPIE 4623, Functional Monitoring and Drug-Tissue Interaction, pg 68 (5 June 2002); doi: 10.1117/12.469474
Proc. SPIE 4623, Functional Monitoring and Drug-Tissue Interaction, pg 77 (5 June 2002); doi: 10.1117/12.491244
Instrumentation: Optical Tools, Materials, and Techniques
Proc. SPIE 4623, Functional Monitoring and Drug-Tissue Interaction, pg 94 (5 June 2002); doi: 10.1117/12.469437
Proc. SPIE 4623, Functional Monitoring and Drug-Tissue Interaction, pg 102 (5 June 2002); doi: 10.1117/12.469438
Proc. SPIE 4623, Functional Monitoring and Drug-Tissue Interaction, pg 110 (5 June 2002); doi: 10.1117/12.469439
Histograms, Imaging, Tomography, Catchment Volumes, Penetration Depth
Proc. SPIE 4623, Functional Monitoring and Drug-Tissue Interaction, pg 116 (5 June 2002); doi: 10.1117/12.469440
Proc. SPIE 4623, Functional Monitoring and Drug-Tissue Interaction, pg 134 (5 June 2002); doi: 10.1117/12.469441
Proc. SPIE 4623, Functional Monitoring and Drug-Tissue Interaction, pg 144 (5 June 2002); doi: 10.1117/12.469442
Muscle and Skin Monitoring
Proc. SPIE 4623, Functional Monitoring and Drug-Tissue Interaction, pg 153 (5 June 2002); doi: 10.1117/12.469443
Proc. SPIE 4623, Functional Monitoring and Drug-Tissue Interaction, pg 162 (5 June 2002); doi: 10.1117/12.469445
Proc. SPIE 4623, Functional Monitoring and Drug-Tissue Interaction, pg 170 (5 June 2002); doi: 10.1117/12.491259
Proc. SPIE 4623, Functional Monitoring and Drug-Tissue Interaction, pg 178 (5 June 2002); doi: 10.1117/12.469446
Proc. SPIE 4623, Functional Monitoring and Drug-Tissue Interaction, pg 187 (5 June 2002); doi: 10.1117/12.469447
Proc. SPIE 4623, Functional Monitoring and Drug-Tissue Interaction, pg 195 (5 June 2002); doi: 10.1117/12.491252
Brain Monitoring
Proc. SPIE 4623, Functional Monitoring and Drug-Tissue Interaction, pg 206 (5 June 2002); doi: 10.1117/12.491257
Subcellular Structures in Perfused Heart
Proc. SPIE 4623, Functional Monitoring and Drug-Tissue Interaction, pg 214 (5 June 2002); doi: 10.1117/12.469448
Proc. SPIE 4623, Functional Monitoring and Drug-Tissue Interaction, pg 224 (5 June 2002); doi: 10.1117/12.469449
Proc. SPIE 4623, Functional Monitoring and Drug-Tissue Interaction, pg 231 (5 June 2002); doi: 10.1117/12.469451
Proc. SPIE 4623, Functional Monitoring and Drug-Tissue Interaction, pg 236 (5 June 2002); doi: 10.1117/12.469452
Proc. SPIE 4623, Functional Monitoring and Drug-Tissue Interaction, pg 246 (5 June 2002); doi: 10.1117/12.469453
Proc. SPIE 4623, Functional Monitoring and Drug-Tissue Interaction, pg 254 (5 June 2002); doi: 10.1117/12.469454
Proc. SPIE 4623, Functional Monitoring and Drug-Tissue Interaction, pg 266 (5 June 2002); doi: 10.1117/12.469455
Proc. SPIE 4623, Functional Monitoring and Drug-Tissue Interaction, pg 274 (5 June 2002); doi: 10.1117/12.491250
Monitoring in Intensive Care Units
Proc. SPIE 4623, Functional Monitoring and Drug-Tissue Interaction, pg 287 (5 June 2002); doi: 10.1117/12.469456
Proc. SPIE 4623, Functional Monitoring and Drug-Tissue Interaction, pg 293 (5 June 2002); doi: 10.1117/12.469457
Functional Monitoring in Perfused Liver and in Liver in Situ
Proc. SPIE 4623, Functional Monitoring and Drug-Tissue Interaction, pg 300 (5 June 2002); doi: 10.1117/12.469459
Proc. SPIE 4623, Functional Monitoring and Drug-Tissue Interaction, pg 324 (5 June 2002); doi: 10.1117/12.469460
Proc. SPIE 4623, Functional Monitoring and Drug-Tissue Interaction, pg 314 (5 June 2002); doi: 10.1117/12.469461
Proc. SPIE 4623, Functional Monitoring and Drug-Tissue Interaction, pg 308 (5 June 2002); doi: 10.1117/12.469462
Proc. SPIE 4623, Functional Monitoring and Drug-Tissue Interaction, pg 332 (5 June 2002); doi: 10.1117/12.469463
Tumor Imaging in Microvolumes, Sub- and Supracellular Spaces by Use of Various Optical Sensor Systems and Chromophores
Proc. SPIE 4623, Functional Monitoring and Drug-Tissue Interaction, pg 339 (5 June 2002); doi: 10.1117/12.469465
Proc. SPIE 4623, Functional Monitoring and Drug-Tissue Interaction, pg 346 (5 June 2002); doi: 10.1117/12.469466
Proc. SPIE 4623, Functional Monitoring and Drug-Tissue Interaction, pg 358 (5 June 2002); doi: 10.1117/12.469467
Local Drug Effects on Functional Structures in Tissues: Response of Pigments, Chromophores, and Light Scattering
Proc. SPIE 4623, Functional Monitoring and Drug-Tissue Interaction, pg 370 (5 June 2002); doi: 10.1117/12.469468
Proc. SPIE 4623, Functional Monitoring and Drug-Tissue Interaction, pg 384 (5 June 2002); doi: 10.1117/12.469469
Proc. SPIE 4623, Functional Monitoring and Drug-Tissue Interaction, pg 376 (5 June 2002); doi: 10.1117/12.469470
Subcellular Structures in Perfused Heart
Proc. SPIE 4623, Functional Monitoring and Drug-Tissue Interaction, pg 281 (5 June 2002); doi: 10.1117/12.469472
Histograms, Imaging, Tomography, Catchment Volumes, Penetration Depth
Proc. SPIE 4623, Functional Monitoring and Drug-Tissue Interaction, pg 124 (5 June 2002); doi: 10.1117/12.469473
Back to Top